Relievant Appoints Christopher Geyen Chief Financial Officer

Written By Shannon Beyer

SUNNYVALE, Calif., March 06, 2018 (GLOBE NEWSWIRE) — Relievant Medsystems, a privately held medical device company that has developed the Intracept® Procedure, a minimally invasive and clinically proven approach for the treatment of chronic low back pain, announced today the appointment of Christopher Geyen as Chief Financial Officer.  Mr. Geyen will report to Relievant’s Chief Executive Officer, Kevin Hykes.

Shannon Beyer
Previous

Procyrion Names Elisabeth Neely Senior Vice President of Clinical and Regulatory Affairs, Formerly with Abbott
Next

Respicardia Announces First U.S. Commercial Case with the remedē® System; Industry Veteran Peter Sommerness Joins as CEO to Lead U.S. Launch